News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
866,637 Results
Type
Article (87735)
Company Profile (824)
Press Release (778059)
Multimedia
Podcasts (186)
Webinars (28)
Section
Business (233166)
Career Advice (4143)
Deals (39830)
Drug Delivery (144)
Drug Development (91350)
Employer Resources (203)
FDA (18348)
Job Trends (17414)
News (397686)
Policy (39946)
Tag
Academia (3006)
Academic (2)
Accelerated approval (25)
Adcomms (35)
Allergies (134)
Alliances (56980)
ALS (166)
Alzheimer's disease (1755)
Antibody-drug conjugate (ADC) (301)
Approvals (18437)
Artificial intelligence (577)
Autoimmune disease (129)
Automation (33)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (186)
Biotechnology (488)
Bladder cancer (149)
Brain cancer (61)
Breast cancer (599)
Cancer (4621)
Cardiovascular disease (406)
Career advice (3565)
Career pathing (40)
CAR-T (288)
CDC (59)
Celiac Disease (1)
Cell therapy (780)
Cervical cancer (36)
Clinical research (76456)
Collaboration (1577)
Company closure (5)
Compensation (1055)
Complete response letters (65)
COVID-19 (2974)
CRISPR (93)
C-suite (727)
Cystic fibrosis (147)
Data (5738)
Decentralized trials (2)
Denatured (68)
Depression (131)
Diabetes (491)
Diagnostics (7162)
Digital health (42)
Diversity (12)
Diversity, equity & inclusion (49)
Drug discovery (267)
Drug pricing (206)
Drug shortages (36)
Duchenne muscular dystrophy (221)
Earnings (99874)
Editorial (59)
Employer branding (25)
Employer resources (173)
Events (134460)
Executive appointments (1009)
FDA (21160)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1425)
Gene editing (201)
Generative AI (60)
Gene therapy (617)
GLP-1 (1081)
Government (5417)
Grass and pollen (8)
Guidances (379)
Healthcare (20941)
HIV (54)
Huntington's disease (44)
IgA nephropathy (80)
Immunology and inflammation (271)
Immuno-oncology (35)
Indications (74)
Infectious disease (3242)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (111)
Intellectual property (214)
Interviews (816)
IPO (17942)
IRA (59)
Job creations (5198)
Job search strategy (2866)
Kidney cancer (17)
Labor market (88)
Layoffs (652)
Leadership (38)
Legal (10153)
Liver cancer (94)
Longevity (14)
Lung cancer (642)
Lymphoma (357)
Machine learning (40)
Management (66)
Manufacturing (735)
MASH (164)
Medical device (14965)
Medtech (15004)
Mergers & acquisitions (22861)
Metabolic disorders (1278)
Multiple sclerosis (148)
NASH (23)
Neurodegenerative disease (321)
Neuropsychiatric disorders (85)
Neuroscience (2939)
NextGen: Class of 2025 (7703)
Non-profit (5102)
Now hiring (61)
Obesity (611)
Opinion (326)
Ovarian cancer (152)
Pain (183)
Pancreatic cancer (198)
Parkinson's disease (270)
Partnered (34)
Patents (463)
Patient recruitment (395)
Peanut (58)
People (66605)
Pharmaceutical (145)
Pharmacy benefit managers (30)
Phase I (23610)
Phase II (33188)
Phase III (25006)
Pipeline (3765)
Policy (318)
Postmarket research (3554)
Preclinical (10658)
Press Release (72)
Prostate cancer (226)
Psychedelics (52)
Radiopharmaceuticals (284)
Rare diseases (795)
Real estate (7435)
Recruiting (80)
Regulatory (28497)
Reports (65)
Research institute (2715)
Resumes & cover letters (651)
Rett syndrome (23)
RNA editing (16)
RSV (82)
Schizophrenia (147)
Series A (233)
Series B (177)
Service/supplier (30)
Sickle cell disease (99)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (46)
Startups (4324)
State (2)
Stomach cancer (19)
Supply chain (106)
Tariffs (97)
The Weekly (116)
Vaccines (1100)
Venture capital (76)
Weight loss (429)
Women's health (76)
Worklife (21)
Date
Today (75)
Last 7 days (637)
Last 30 days (2828)
Last 365 days (33381)
2025 (32173)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1288)
Alabama (85)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (51290)
Australia (9013)
California (10736)
Canada (3146)
China (1039)
Colorado (453)
Connecticut (479)
Delaware (320)
Europe (117912)
Florida (1574)
Georgia (348)
Hawaii (3)
Idaho (68)
Illinois (884)
India (62)
Indiana (517)
Iowa (22)
Japan (373)
Kansas (130)
Kentucky (41)
Louisiana (28)
Maine (81)
Maryland (1394)
Massachusetts (7963)
Michigan (339)
Minnesota (623)
Mississippi (6)
Missouri (132)
Montana (34)
Nebraska (27)
Nevada (117)
New Hampshire (81)
New Jersey (2937)
New Mexico (32)
New York (2874)
North Carolina (1526)
North Dakota (10)
Northern California (5049)
Ohio (326)
Oklahoma (22)
Oregon (52)
Pennsylvania (2179)
Puerto Rico (20)
Rhode Island (48)
South America (1656)
South Carolina (60)
South Dakota (1)
Southern California (4122)
Tennessee (165)
Texas (1684)
United States (39092)
Utah (323)
Vermont (1)
Virginia (270)
Washington D.C. (85)
Washington State (904)
West Virginia (4)
Wisconsin (111)
Wyoming (2)
There are 866,637 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Parkinson’s disease
AC Immune’s Parkinson’s Immunotherapy Appears to Slow Disease Progression
In a first for the Parkinson’s field, AC Immune’s immunotherapy has stabilized key biomarkers that suggest an effect on the disease’s course.
December 11, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
BioVersys Announces BV100 Phase 3 Initiation and Provides a Business Update
December 11, 2025
·
8 min read
Press Releases
Sequana Medical Announces U.S. Commercial alfapump® Implantations at University of Pennsylvania
December 11, 2025
·
8 min read
Press Releases
Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases
December 11, 2025
·
11 min read
Press Releases
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu
December 11, 2025
·
5 min read
Press Releases
Addex Amends its at the Market Offering Agreement With H.C. Wainwright & Co.
December 11, 2025
·
4 min read
Press Releases
Basilea and Phare Bio enter partnership combining anti-infectives industry expertise with unique AI capabilities for the development of a novel antibiotic
December 11, 2025
·
3 min read
Press Releases
Updated Efficacy Data of Ivonescimab Combined with Chemotherapy as First-Line Treatment for TNBC Presented at ESMO IO 2025
December 11, 2025
·
5 min read
Layoff Tracker
Adare Shuts Down Philadelphia Plant, Leaving 137 Jobless
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
December 11, 2025
·
93 min read
·
BioSpace Editorial Staff
Obesity
Lilly’s Retatrutide Scores Triple Trial Triumph With 26% Weight Loss, But New Safety Signal Emerges
Analysts were hoping for a safety profile similar to what was achieved in Phase II but an abnormal sense of touch, called dysesthesia, has emerged in the late-stage TRIUMPH-4 trial.
December 11, 2025
·
3 min read
·
Annalee Armstrong
1 of 86,664
Next
